Cancer
from24/7 Wall St.
4 days agoX4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst Attention
Three small-cap biotechs have received positive analyst coverage with Buy-equivalent ratings and substantial price target upside ahead of 2026 clinical catalysts.